Manapad, Samra S.
HRN: 21-95-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2022
CEFUROXIME 1.5GM (VIAL)
10/12/2022
10/12/2022
IV
1.5gm
On Call To OR
Stat CS For Malpresentation
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes